Anandamide induces apoptosis in human endothelial cells: its regulation system and clinical implications
Anandamide induces apoptosis in human endothelial cells: its regulation system and clinical implications
复制标题
DOI:
10.1055/s-0037-1613475
复制
发表时间:
2003-05
影响因子:
6.7
通讯作者:
K. Yamaji;K. Sarker;K. Kawahara;S. Iino;M. Yamakuchi;K. Abeyama;T. Hashiguchi;I. Maruyama
中科院分区:
文献类型:
--
作者:
K. Yamaji;K. Sarker;K. Kawahara;S. Iino;M. Yamakuchi;K. Abeyama;T. Hashiguchi;I. Maruyama
Summary Anandamide (AEA), an endogenous cannabinoid, is generated by macrophages during shock conditions, and is thought to be a causative mediator of septic shock. Thus, we hypothesized that AEA plays a crucial role in endothelial cell (EC) injury. Here, we demonstrate that AEA induces apoptosis in a time-and dose-dependent manner in human umbilical vein endothelial cells (HUVECs). AEA triggered phosphorylation of c-Jun NH2-terminal kinase (JNK) and p38 mitogen activated protein kinase. AEA also showed a marked increase of interleukin 1β–converting enzyme (ICE)CED-3 family protease (caspase-3) activity. AEA-induced EC death was inhibited by a selective vanilloid receptor 1 (VR1) antagonist, capsazepine, and was enhanced by a VR1 agonist, capsaicin, indicating that AEA induces apoptosis in ECs via VR1. In conclusion, we propose that AEA may play a crucial role in EC injury under conditions of shock, and that the use of inhibitors of the AEA regulation system may have a therapeutic effect under these conditions.